Navigation Links
ISPE Conference to Benchmark and Advance Quality by Design in the Biopharmaceutical Industry
Date:3/7/2013

TAMPA, Fla., March 7, 2013 /PRNewswire/ -- ISPE announced today that it will hold its first-ever conference focused on benchmarking and advancing the development of Quality by Design (QbD) in the biopharmaceutical industry. The two-day event, taking place 10 – 11 April 2013 in San Francisco, Calif. USA, will feature workshops and discussions on the industry's progress since the introduction of A-Mab and steps for further adoption of QbD principles. The conference is endorsed by CASSS, a not-for-profit 501(c)(6) professional scientific society made up of over 4,000 industry, academic and public sector professionals.

"Quality by Design is a critical issue for the industry, with companies and global regulatory authorities working to help the industry adopt QbD practices," said Nancy Berg , ISPE President and CEO. "As the global pharmaceutical association representing the entire pharmaceutical lifecycle, ISPE will bring together top QbD experts to discuss how planning and controlling product evolution can lead to superior quality, better resource use and increased business effectiveness."

The State of Quality by Design in the Biopharmaceutical Industry Conference will offer in-depth case studies, lessons learned and best practices in implementing QbD. Pfizer's Roger Nosal , Vice President, Global Chemistry, Manufacturing and Controls (GCMC), will present a plenary address titled "Carpe Opportunite: Regulatory Experience with Implementation of QbD, An Industry Perspective." Mr. Nosal has an extensive history of leading advanced technology dialog among industry and regulators.

Speakers and delegates from Abbott, Amgen, Eli Lilly, Genentech, MedImmune, Merck, Pfizer, Roche and more will explore challenges and solutions with industry and regulatory experts and peers in workshops on design space, control strategies, successful dossiers and lifecycle management. The content of these workshops will be infused with attendees' pre-conference input, resulting in discussions specifically tailored to audience concerns. After the event, aggregate workshop results will be compiled and re-structured to produce a set of proposed QbD solutions that will be carried forward to US and European health authorities.

More information on The State of Quality by Design in the Biopharmaceutical Industry Conference, including complete education details and registration information, is available at www.ISPE.org/2013QbDConference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
8. PRA Expert to Present at Pharmacovigilance Conference
9. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
10. Verenium to Present at Baird Clean Technology Conference
11. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):